| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Thomas F Franke last filed a Form 4 in May 2016, as Director at OHI. Thomas F Franke's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,000 shares of OHI. Net of sales, the OHI filings show accumulation of 22,000 shares.
Thomas F Franke has 8 Form 4 filings on record from February 2015 to May 2016, all as Director at Omega Healthcare Investors (OHI), 2015–2016.
The 15 reported transactions were 9 open-market purchases and 6 stock awards.
Counted by filing, the open-market trades come to 2 purchases worth about $644K and no sales.
The largest open-market purchase was 16,000 shares of OHI at an average $28.62 on February 12, 2016, about $458K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2016. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.